Page 100 - Annual Report
P. 100

HONG KONG ACADEMY OF MEDICINE                                                                                          HONG KONG ACADEMY OF MEDICINE
                 香 香港醫學專科學院                                                                                                             香 香港醫學專科學院
                   港
                                                                                                                                                  科
                              院
                                                                                                                                              學
                     醫
                                                                                                                                                專
                       學
                         專
                                                                                                                                                   學
                                                                                                                                          港
                                                                                                                                            醫
                           科
                            學
                                                                                                                                                     院
                 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS                                                                         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
                 FOR THE YEAR ENDED 31 DECEMBER 2024                                                                                    FOR THE YEAR ENDED 31 DECEMBER 2024



                 16.  RESERVE AND FUNDS (Continued)                                                                                     19.  FINANCIAL INSTRUMENTS

                     The Academy (Continued)                                                                                                The  Group’s  major  financial  instruments  include  investments  in  equity  instruments  designated  at
                                                                                                                                            FVTOCI, receivables, time deposits, cash and cash equivalents and accruals and other payables.
                      Fair  value  reserve  comprises  the  cumulative  net  change  in  the  fair  value  of  equity  instruments          Details of the financial instruments are disclosed in the respective notes. The risk associated with
                     designated at FVTOCI held at the end of the reporting period and is dealt with in accordance with the                  these financial instruments include credit risk, liquidity risk, currency risk, interest rate risk and price
                     accounting policy in note 2(h). Funds received are accounted for in the Foundation fund which is                       risk. The policies on how to mitigate these risks are set out below. The management manages and
                     used exclusively for the establishment and use of the Academy at such time as the Academy shall                        monitors these exposures to ensure appropriate measures are implemented on a timely and effective
                     direct. General fund represents the cumulative surplus of the Academy.                                                 manner.

                                                                                                                                            a)   Credit risk
                 17.  CAPITAL MANAGEMENT
                                                                                                                                                 The Group’s credit risk is primarily attributable to receivables, time deposits and cash and cash
                     The Group defined all components of reserve and funds as “capital”. On this basis, the amount of                            equivalents. Management has a credit policy in place and the exposures to these credit risks are
                     capital employed at 31 December 2024 was HK$97,867,147 (2023: HK$99,384,740).                                               monitored on an ongoing basis.

                     The  Group’s  primary  objectives  when  managing  capital  are  to  safeguard  the  Group’s  ability  to                   i)   In  respect  of  the  receivables,  in  order  to  minimize  risk,  the  management  has  a  credit
                     continue as a going concern.                                                                                                     policy in place and the exposures to these credit risks are monitored on an ongoing basis.
                                                                                                                                                      Credit evaluations of its debtor’s financial position and condition is performed on each and
                     The  Group’s  capital  structure  is  regularly  reviewed  and  managed.  Adjustments  are  made  to  the                        every major debtor periodically. These evaluations focus on the debtor’s past history of
                     capital structure in light of changes in economic conditions affecting the Group, to the extent that                             making payments when due and current ability to pay, and take into account information
                     these do not conflict with the Council’s fiduciary duties towards the Group or the requirements of the                           specific  to  the  debtor.  The  Group  does  not  require  collateral  in  respect  of  its financial
                     Hong Kong Academy of Medicine Ordinance.                                                                                         assets. The Group also takes into account the economic environment in which the debtor
                                                                                                                                                      operates.
                     The Group was not subject to externally imposed capital requirements in either the current or prior
                     year.                                                                                                                       ii)   The investments in equity instruments designated at FVTOCI are liquid securities listed on
                                                                                                                                                      the recognised stock exchanges. Given their high credit standing, management does not
                                                                                                                                                      expect any investment counterparty to fail to meet its obligations.
                 18.  COMMITMENTS
                                                                                                                                                 iii)   The credit risk on liquid funds is limited because the counterparties are banks with high
                     Lease commitment                                                                                                                 credit ratings assigned by international credit - rating agencies.

                     The Academy as lessor                                                                                                       iv)   The Group does not provide any guarantees which would expose the Group to the credit
                                                                                                                                                      risk.
                     Undiscounted lease payments under non-cancellable operating leases in place at the reporting date
                     will be receivable by the Academy in future periods as follows:                                                        b)   Liquidity risk

                                                                                   2024              2023                                        The Group’s policy is to regularly monitor current and expected liquidity requirements to ensure
                                                                                   HK$               HK$                                         that it maintains sufficient reserves of cash and readily realisable marketable securities and/or
                                                                                                                                                 from other groups to meet its liquidity requirements in the short and longer term.
                     Within 1 year                                              391,500           378,000
                     After 1 year but within 5 years                            216,000            67,500                                        The following liquidity tables show the remaining contractual maturities at the end of reporting
                                                                                                                                                 period  of  the  Group’s  non-derivative  financial  liabilities,  which  are  based  on  contractual
                                                                                607,500           445,500                                        undiscounted cash flows and the earliest date the Group can be required to pay.

                     The Academy leases out certain areas of its headquarter under operating leases. None of the leases
                     includes contingent rentals.









                                                            27                                                                                                                     28







     98          HKAM Annual Report 2025
   95   96   97   98   99   100   101   102   103   104   105